This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
A couple of days at the beach was just what I needed to get over the jet lag from the multiple trips I’ve taken in the past month. This week I’m posting an interview I had with Dr. Anthony Mato from UPenn when we talked at ASH 2016 about the real-world research he has been doing patients being treated with ibrutinib both in the community and academic settings, and not just within clinical trials. You can view my summary, watch the interview or read the transcript here.
We’re working on the content for the next issue of The CLL Tribune, so if you have a question for our Ask the Doctor section, you can submit it here. No question is too silly to ask and you can be sure others have the same questions.
CLL Patient Support Group Meetings This Week
Thursday, May 25th at 6:45 PM in Denver, Colorado – the Denver CLL Support Group, sponsored by the CLL Society will be meeting for the FIRST time. More information here.
ALSO – We are actively forming CLL-specific support group in a number of cities around the country. To see if your city is one of them, click here and select the interest survey for your city. JUST ADDED – Hartford, CT and Nashville, TN. Not listed, but interested in starting one? Email us at email@example.com Thanks!
Upcoming Patient Education Meetings
- Saturday, May 27th from 9:00 AM to 1:00 PM PT in Duarte, CA: The Leukemia and Lymphoma Society will be hosting 2017 What Matters For Survivors Of Blood Cancers at the Cooper Auditorium at City of Hope in Duarte, California. Find out more information and register here.
In the meantime….
We are all in this together.
Brian Koffman, MD